• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - weight loss drug - Page 2
Tag:

weight loss drug

Health

Fat, skinny and skinny-fat: A weight-loss drug may not be the answer

by Chief Editor March 30, 2025
written by Chief Editor

The health/” title=”How to lose weight after 50? Dietician shares simple steps to shed pounds and stay …y | …”>Future of Weight Management: Beyond the Pill

As society becomes increasingly conscious of health, the dialogue surrounding weight management has reached new heights, led in part by celebrities like Whoopi Goldberg, who advocates for awareness via her experience with weight-loss drugs like Mounjaro. This spotlight not only highlights the potential of pharmacological solutions but also emphasizes the necessity of maintaining a holistic approach to health—a balance where pharmaceutical aid is part of a broader strategy.

Emergence of New-Gen Weight-Loss Pharmaceuticals

The recent breakthroughs in weight-loss drugs promise swift impact, with medications potentially reducing body weight by up to 20%. These advancements, however, carry a reminder: they should be enhancers, not replacements, of the lifestyle modifications essential for sustained well-being. Moreover, despite their potential, such drugs are often expensive, making them out of reach for many—a stark reflection of current healthcare inequalities.

Did you know? The obesity drugs market is projected to be worth around $200 billion by 2030, signifying the vast economic implications alongside medical uses.

Restructuring Health Narratives

Health narratives have long been skewed by societal perceptions—often elevating aesthetic considerations over true health markers. It’s essential to redefine body weight as a significant health indicator rather than merely a point of social scrutiny. In 2025, this perception began to shift, with more people recognizing weight as an indication to undergo comprehensive health assessments, identifying and treating underlying conditions early.

Pro Tip: Always discuss your health concerns with a professional who can provide personalized advice beyond societal narratives.

Dietary Culture: Reimagining Home-Cooked Traditions

Culturally-ingrained food habits, such as the intake of carbohydrate-rich meals and sugary treats, necessitate reconsideration. Emerging data spotlight the dangers of a “skinny-fat” lifestyle, in which individuals might not appear overweight but suffer from abdominal obesity. A pivot towards balanced diets is vital—emphasizing protein intake and adopting mindful eating practices.

Technological Influence on Physical Activity

As technological advancements reduce physical exertion in daily life, integrating activity into routines becomes imperative. Exercises once limited to gyms should now be accessible to all age demographics, promoting mobility and longevity. This transition should focus on making physical activity a culturally ingrained aspect of life, not just an optional exercise.

FAQs on Weight Management Trends

How important are lifestyle changes compared to pharmaceutical aids?

Lifestyle changes—diet, exercise, and overall behavior—are the cornerstone of effective weight management, with pharmaceutical aids acting as supportive accelerators.

Are weight-loss drugs accessible for the average person?

Currently, the high cost of weight-loss drugs poses a barrier, highlighting the disparity in access—an issue that needs reshaping for inclusivity.

Can traditional dietary practices adapt to modern health insights?

Yes, traditional dietary habits can embrace modern health insights by incorporating balanced nutrients while reducing unnecessary sugars and fats.

Call to Action

Stay informed and engaged in your health journey by exploring further on our site. Feel free to comment below, share your experiences, or subscribe to our newsletter for more insights and tips. Join the conversation and ensure optimal health is within everyone’s reach.

March 30, 2025 0 comments
0 FacebookTwitterPinterestEmail
Health

Eli Lilly launches its blockbuster weight loss drug Mounjaro in India

by Chief Editor March 21, 2025
written by Chief Editor

The Rise of Weight-Loss Pharmaceuticals in India

The Indian pharmaceutical landscape is witnessing a significant transformation with the introduction of weight-loss drugs like Mounjaro by Eli Lilly & Co. This revolutionary drug, priced at ₹14,000 to ₹17,500 per month, is tailored for the Indian market, marking a competitive entry into the burgeoning sector of GLP-1 hormone receptor activators. The introduction of such drugs will cater to India’s increasing obesity and type-2 diabetes challenges, addressing the dual burden of these health conditions.

Mounjaro’s Strategic Launch and Potential Market Impact

Eli Lilly has strategically positioned Mounjaro at a competitive price point of ₹3,500 and ₹4,375 for its 2.5mg and 5mg vials. This decision reflects the company’s commitment to making innovative treatments more accessible in India. The drug’s unique mechanism—activating GIP and GLP-1 hormone receptors—enhances its appeal for treating obesity and type-2 diabetes, signaling a potential shift in therapeutic approaches within the region.

According to Systematix Group’s senior vice-president, Vishal Manchanda, GLP-1 drugs hold substantial market potential, with projections indicating a market size of $100 billion by 2030. The competition is heating up, as other pharmaceutical companies gear up to introduce similar products. The impending absence of Ozempic’s patent in 2026 is poised to allow generic entries, significantly lowering prices and broadening accessibility.

Competition and Market Dynamics

Mounjaro’s first-mover advantage in India is temporary, as generic versions of semaglutide (Ozempic) by top generics manufacturers, including Cipla and Dr Reddy’s, are expected to enter the fray post-2026. Sun Pharmaceutical Industries is also in the race with its developmental pipeline for a GLP-1 drug. Novo Nordisk has announced plans for Ozempic’s launch, although without a defined timeline, adding another layer of intrigue to the market scenario.

Medical Perspective and Patient Impact

Dr. Rajiv Kovil, a senior diabetologist, notes that “at least 50% of [type 2 diabetes] patients are overweight,” underscoring the high demand for intervention drugs like Mounjaro. Experts project significant uptake among diabetics, attributing to both effectiveness and currently lower awareness levels among the general populace. This dual patient base could lead to substantial revenue for Eli Lilly, assuming even modest market penetration.

Growing Obesity Concerns

A Lancet study projects a staggering rise in obesity levels in India, with numbers potentially reaching 450 million by 2050. The growing obesity epidemic, coupled with an increase in diabetes cases, emphasizes the urgency for effective pharmaceutical interventions. Market reports have affirmed a burgeoning GLP-1 drug market in India, initially driven by authorized prescriptions and supplemented by unauthorized grey market activities.

Implications for the Indian Market

The diabetes drug market has been evaluated around ₹17,000 crore as of 2024. Eli Lilly’s global revenue from Mounjaro surged by 60%, indicating robust international demand potentially mirrored in India. The Indian Council of Medical Research estimates nearly 101 million people with diabetes, with a significant portion on medication, underscoring the vast potential market for Mounjaro and similar GLP-1 drugs.

FAQs About Weight-Loss Pharmaceuticals in India

  • What is Mounjaro?

    Mounjaro (tirzepatide) is a weight-loss drug that activates GIP and GLP-1 hormone receptors, managing blood sugar and promoting satiety.

  • Who will primarily benefit from Mounjaro?

    Individuals with obesity and type-2 diabetes are the main target beneficiaries of Mounjaro’s therapeutic effects.

  • How will the market change post-Ozempic’s patent expiration?

    The expiry will likely result in generic versions becoming available, driving prices down and increasing accessibility for a broader population.

Toward a Healthier Future: Engagement and Next Steps

As the GLP-1 drug market in India continues to evolve, consumer awareness and access remain pivotal. Readers are encouraged to comment below with thoughts on the evolving pharmaceutical landscape or subscribe to our newsletter for the latest updates and insights on health innovations.

March 21, 2025 0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Recent Posts

  • TLC’s Deon Derrico Files Lawsuit Over Real Estate Dispute

    June 28, 2026
  • Chelsea Gray Reaches Major Milestone, Solidifying Hall of Fame Resume

    June 28, 2026
  • Diabetes Fueling Early Cataract Cases in India: Mumbai Doctor’s Warning

    June 28, 2026
  • From Whithorn to the World: A Leading Scientist’s Journey

    June 28, 2026
  • Student Found Dead Near Train Station After Being Overlooked by Thousands

    June 28, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: o f f i c e @byohosting.com


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World